30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

Aurora Spine Reports 1Q19 Revenue of $2.7MM, +81.2% vs. 1Q18 -



Aurora Spine reports 1Q19 revenue of USD $2.7MM, +81.2% vs. 1Q18.

  • Highest quarterly revenue in company history
  • Granted patent on “Expandable Interspinous Device” relating to minimally invasive implants
  • Completing development of posterior SI joint products and the ZIP-Flex interlaminar fixation device


ORTHOWORLD estimates segment sales and growth on an as-reported basis as follows ($MM).

  1Q19 1Q18 $ Chg % Chg
Spine $2.6 $1.4 $1.2 82.5%
Orthobiologics $0.2 $0.1 $0.1 66.4%
Total $2.7 $1.5 $1.2 81.5%

Net earnings are as follows ($MM).

1Q19 Amount % of Sales
Sales $2.7  
   Cost of Sales -$1.6 57.3%
   Operating Expenses -$1.4 50.2%
Net Earnings -$0.2 -7.5%


Source: Aurora Spine Corporation; ORTHOWORLD estimates

Mike Evers is ORTHOWORLD’s Market Analyst. He can be reached by email.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.